Orthopaedic Department, Oslo University Hospital Aker, Norway.
Injury. 2010 Jun;41(6):599-605. doi: 10.1016/j.injury.2009.10.056. Epub 2009 Nov 27.
This study aims to evaluate the costs and health outcome for surgical and conservative treatment of displaced proximal humeral fractures.
This study is a randomised controlled trial.
This study included 50 patients aged 60 or older admitted to hospital with a severely displaced three- or four-part fracture.
The patients were treated surgically with an angular stable interlocking implant (25 patients) or conservative treatment (25 patients).
The outcomes measured included quality-adjusted life years (QALYs) and societal costs.
At 12 months' follow-up, the mean difference in the number of QALYs was 0.027 (95% confidence interval (CI)=-0.025, 0.078) while the mean difference in total health-care costs was 597 euro in favour of surgery (95% CI=-5291, 3777).
There was no significant difference in QALYs or costs between surgical and conservative treatment of severe displaced proximal humeral fractures.
本研究旨在评估手术与保守治疗移位性肱骨近端骨折的成本和健康结局。
这是一项随机对照试验。
本研究纳入了 50 名年龄在 60 岁及以上因严重三或四部分移位骨折而住院的患者。
患者接受了角稳定锁定植入物（25 例）或保守治疗（25 例）。
测量的结果包括质量调整生命年（QALYs）和社会成本。
在 12 个月的随访中，QALY 的平均差值为 0.027（95%置信区间（CI）=-0.025，0.078），而手术治疗的总医疗保健费用平均差值为 597 欧元（95% CI=-5291，3777）。
严重移位性肱骨近端骨折的手术与保守治疗在 QALYs 或成本方面无显著差异。
